Jeffrey Schein

2.6k total citations
58 papers, 1.9k citations indexed

About

Jeffrey Schein is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Epidemiology. According to data from OpenAlex, Jeffrey Schein has authored 58 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Cardiology and Cardiovascular Medicine, 8 papers in Internal Medicine and 8 papers in Epidemiology. Recurrent topics in Jeffrey Schein's work include Atrial Fibrillation Management and Outcomes (26 papers), Venous Thromboembolism Diagnosis and Management (8 papers) and Cardiac Arrhythmias and Treatments (8 papers). Jeffrey Schein is often cited by papers focused on Atrial Fibrillation Management and Outcomes (26 papers), Venous Thromboembolism Diagnosis and Management (8 papers) and Cardiac Arrhythmias and Treatments (8 papers). Jeffrey Schein collaborates with scholars based in United States, Canada and Belgium. Jeffrey Schein's co-authors include Winnie W. Nelson, Patrick Lefèbvre, François Laliberté, Bruce Ettinger, Alice Pressman, Christie M. Ballantyne, Félix Arellano, Craig I Coleman, Jitender Sethi and Gilbert Honigfeld and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and The American Journal of Cardiology.

In The Last Decade

Jeffrey Schein

54 papers receiving 1.8k citations

Peers

Countries citing papers authored by Jeffrey Schein

Since Specialization

Citations

This map shows the geographic impact of Jeffrey Schein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey Schein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey Schein more than expected).

Fields of papers citing papers by Jeffrey Schein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey Schein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey Schein. The network helps show where Jeffrey Schein may publish in the future.

Co-authorship network of co-authors of Jeffrey Schein

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey Schein. A scholar is included among the top collaborators of Jeffrey Schein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey Schein. Jeffrey Schein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Real world analysis of treatment change and response in adults with attention-deficit/hyperactivity disorder (ADHD) alone and with concomitant psychiatric comorbidities: results from an electronic health record database study in the United States 2024 ·BMC Psychiatry ·(unknown), Jeffrey Schein, (unknown), Xueyan Huang, (unknown), Ann Childress, Scott H. Kollins, Sandipan Bhattacharjee	3
2	PCR78 Treatment Preferences of Adult Patients With Attention-Deficit/Hyperactivity Disorder in Canada: A Discrete Choice Experiment 2024 ·Value in Health ·Jeffrey Schein, Martin Cloutier, (unknown), (unknown), Yaoyao Meng, (unknown), Fan Jiang, Ann Childress	1
3	Prevalence of post-traumatic stress disorder in the United States: a systematic literature review 2021 ·Current Medical Research and Opinion ·Jeffrey Schein, Christy R. Houle, Annette Urganus, Martin Cloutier, Oscar Patterson‐Lomba, Yao Wang, Sarah King, (unknown), Annie Guérin, Patrick Lefèbvre, Lori L. Davis	132
4	ED4 Economic Burden of Attention-Deficit/Hyperactivity Disorder (ADHD) Among Children and Adolescents in the United States (US): A Societal Perspective 2021 ·Value in Health ·Lenard A. Adler, Ann Childress, Martin Cloutier, Patrick Gagnon‐Sanschagrin, M. Davidson, (unknown), A. Guérin, Patrick Lefèbvre, Jeffrey Schein	3
5	Abstract 13611: Adherence to Non-VKA Oral Anticoagulant Medications Based on the Pharmacy Quality Alliance Measure 2015 ·Circulation ·Colleen A. McHorney, Concetta Crivera, François Laliberté, Winnie W. Nelson, (unknown), Brahim Bookhart, (unknown), Jeffrey Schein, Patrick Lefèbvre, Steven Deitelzweig	1
6	Validation of the multivariable In-hospital Mortality for PulmonAry embolism using Claims daTa (IMPACT) prediction rule within an all-payer inpatient administrative claims database 2015 ·BMJ Open ·Craig I Coleman, Christine G. Kohn, Concetta Crivera, Jeffrey Schein, W. Frank Peacock	13
7	Effect of Rivaroxaban Versus Warfarin on Health Care Costs Among Nonvalvular Atrial Fibrillation Patients: Observations from Rivaroxaban Users and Matched Warfarin Users 2015 ·Advances in Therapy ·François Laliberté, Michel Cloutier, Concetta Crivera, Winnie W. Nelson, William H. Olson, Jeffrey Schein, (unknown), (unknown), Patrick Lefèbvre	25
8	Impact of Co-morbidities and Patient Characteristics on International Normalized Ratio Control Over Time in Patients With Nonvalvular Atrial Fibrillation 2013 ·The American Journal of Cardiology ·Winnie W. Nelson, Jiyoon Choi, (unknown), (unknown), Peter Wildgoose, Larry E. Fields, Jeffrey Schein	48
9	Caregiver Assistance Among Medicare Beneficiaries With Atrial Fibrillation and Factors Associated With Anticoagulant Treatment 2012 ·The American journal of geriatric pharmacotherapy ·Shih‐Yin Chen, (unknown), Samir H. Mody, Winnie W. Nelson, Jeffrey Schein, (unknown), Luke Boulanger	3
10	Dyspepsia and Disease Burden Among Patients With Atrial Fibrillation 2012 ·Critical Pathways in Cardiology A Journal of Evidence-Based Medicine ·Joyce LaMori, Samir H. Mody, H.J. Gross, Marco DiBonaventura, Aarti A. Patel, Jeffrey Schein, Winnie W. Nelson	10
11	A Method for Imputing the Impact of Health Problems on At-Work Performance and Productivity From Available Health Data 2009 ·Journal of Occupational and Environmental Medicine ·Debra Lerner, Hong Chang, William H. Rogers, Carmela Benson, Jeffrey Schein, Saralynn Allaire	21
12	Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: A retrospective claims database analysis 2008 ·Clinical Therapeutics ·Xin Ye, Vanja Sikirica, Jeffrey Schein, Richard W. Grant, Victoria Zarotsky, (unknown), Carmela Benson, Aylin Riedel	36
13	Incidence of Constipation Associated with Long-acting Opioid Therapy: A Comparative Study 2004 ·Southern Medical Journal ·Peter S. Staats, (unknown), Jeffrey Schein	57
14	Comparison of Resource Utilization by Patients Treated with Transdermal Fentanyl and Long-Acting Oral Opioids for Nonmalignant Pain 2002 ·Pain Medicine ·Jeanne Loughlin, J. Alexander Cole, Sheri Dodd, Jeffrey Schein, (unknown), Alexander M. Walker	4
15	Patient Satisfaction with Oral versus Nonoral Therapeutic Approaches in Onychomycosis 2001 ·Journal of the American Podiatric Medical Association ·David M. Stier, Douglas Gause, Warren S. Joseph, Jeffrey Schein, Jeanette M. Broering, (unknown), Joseph Doyle	5
16	Osteoporosis therapies for rheumatoid arthritis patients: Minimizing gastrointestinal side effects 2001 ·Seminars in Arthritis and Rheumatism ·K. Lea Sewell, Jeffrey Schein	9
17	Clinic visits and hospital admissions for care of acid-related upper gastrointestinal disorders in women using alendronate for osteoporosis. 1998 ·PubMed ·Bruce Ettinger, Alice Pressman, Jeffrey Schein	116
18	Treatment of patients with mild to moderate hypercholesterolemia: Lipoprotein and Coronary Atherosclerosis Study (LCAS) 1998 ·Christie M. Ballantyne, J. Alan Herd, Jeffrey Schein, Peter H. Jones, John A. Farmer, Antonio M. Gotto	2
19	Maximizing the Cost-effectiveness of Lipid-Lowering Therapy 1998 ·Archives of Internal Medicine ·Terry A. Jacobson, Jeffrey Schein, (unknown), Christie M. Ballantyne	66
20	Epidemiology, Outcomes Research, and Drug Interactions 1998 ·Drug metabolism and drug interactions ·Jeffrey Schein	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact